Methodological and reporting quality of systematic reviews referenced in the clinical practice guideline for pediatric high-blood pressure

Kaleb Vaughn, Mason Skinner, Victoria Vaughn, Cole Wayant, Matt Vassar, Mason Skinner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: To examine the quality of evidence supporting the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. METHODS: Methodological and reporting quality of systematic reviews in the Key Action Statements, Consensus Opinions, and in the reference list were assessed using AMSTAR and The PRISMA checklist. RESULTS: For the systematic reviews within the American Academy of Pediatrics' Guideline as a whole (n = 27), a mean of 47.8% of AMSTAR items were appropriately addressed, and a mean of 61% of PRISMA were appropriately reported. The means for items adhered to in the systematic reviews cited by Key Action Statements (n = 6) were 44.6% for AMSTAR and 67% for PRISMA. The means for items adhered to in the systematic reviews cited by consensus opinion (n = 10) were 41.6% for AMSTAR and 54% for PRISMA. Overall, the AMSTAR and PRISMA scores were highly correlated (r = 0.77). CONCLUSION: This study further substantiates the call for more quality evidence-based research in pediatric hypertension. The overall methodological and reporting quality of the systematic reviews were lacking in the American Academy of Pediatrics Guideline. Assessment of risk of bias across studies, identification of an accessible protocol, full disclosure of the role of funding entities, funding of included studies, and a complete PICOS statement were areas of greatest concern. These deficiencies should be addressed in future research in pediatric hypertension.

Original languageEnglish
Pages (from-to)488-495
Number of pages8
JournalJournal of hypertension
Volume37
Issue number3
DOIs
StatePublished - 1 Mar 2019

Fingerprint

Practice Guidelines
Pediatrics
Hypertension
Consensus
Guidelines
Practice Management
Disclosure
Checklist
Research

Cite this

@article{448fc57922fc4a088d841d74df2df4b2,
title = "Methodological and reporting quality of systematic reviews referenced in the clinical practice guideline for pediatric high-blood pressure",
abstract = "OBJECTIVE: To examine the quality of evidence supporting the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. METHODS: Methodological and reporting quality of systematic reviews in the Key Action Statements, Consensus Opinions, and in the reference list were assessed using AMSTAR and The PRISMA checklist. RESULTS: For the systematic reviews within the American Academy of Pediatrics' Guideline as a whole (n = 27), a mean of 47.8{\%} of AMSTAR items were appropriately addressed, and a mean of 61{\%} of PRISMA were appropriately reported. The means for items adhered to in the systematic reviews cited by Key Action Statements (n = 6) were 44.6{\%} for AMSTAR and 67{\%} for PRISMA. The means for items adhered to in the systematic reviews cited by consensus opinion (n = 10) were 41.6{\%} for AMSTAR and 54{\%} for PRISMA. Overall, the AMSTAR and PRISMA scores were highly correlated (r = 0.77). CONCLUSION: This study further substantiates the call for more quality evidence-based research in pediatric hypertension. The overall methodological and reporting quality of the systematic reviews were lacking in the American Academy of Pediatrics Guideline. Assessment of risk of bias across studies, identification of an accessible protocol, full disclosure of the role of funding entities, funding of included studies, and a complete PICOS statement were areas of greatest concern. These deficiencies should be addressed in future research in pediatric hypertension.",
author = "Kaleb Vaughn and Mason Skinner and Victoria Vaughn and Cole Wayant and Matt Vassar and Mason Skinner",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/HJH.0000000000001870",
language = "English",
volume = "37",
pages = "488--495",
journal = "Journal of hypertension",
issn = "1473-5598",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "3",

}

TY - JOUR

T1 - Methodological and reporting quality of systematic reviews referenced in the clinical practice guideline for pediatric high-blood pressure

AU - Vaughn, Kaleb

AU - Skinner, Mason

AU - Vaughn, Victoria

AU - Wayant, Cole

AU - Vassar, Matt

AU - Skinner, Mason

PY - 2019/3/1

Y1 - 2019/3/1

N2 - OBJECTIVE: To examine the quality of evidence supporting the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. METHODS: Methodological and reporting quality of systematic reviews in the Key Action Statements, Consensus Opinions, and in the reference list were assessed using AMSTAR and The PRISMA checklist. RESULTS: For the systematic reviews within the American Academy of Pediatrics' Guideline as a whole (n = 27), a mean of 47.8% of AMSTAR items were appropriately addressed, and a mean of 61% of PRISMA were appropriately reported. The means for items adhered to in the systematic reviews cited by Key Action Statements (n = 6) were 44.6% for AMSTAR and 67% for PRISMA. The means for items adhered to in the systematic reviews cited by consensus opinion (n = 10) were 41.6% for AMSTAR and 54% for PRISMA. Overall, the AMSTAR and PRISMA scores were highly correlated (r = 0.77). CONCLUSION: This study further substantiates the call for more quality evidence-based research in pediatric hypertension. The overall methodological and reporting quality of the systematic reviews were lacking in the American Academy of Pediatrics Guideline. Assessment of risk of bias across studies, identification of an accessible protocol, full disclosure of the role of funding entities, funding of included studies, and a complete PICOS statement were areas of greatest concern. These deficiencies should be addressed in future research in pediatric hypertension.

AB - OBJECTIVE: To examine the quality of evidence supporting the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. METHODS: Methodological and reporting quality of systematic reviews in the Key Action Statements, Consensus Opinions, and in the reference list were assessed using AMSTAR and The PRISMA checklist. RESULTS: For the systematic reviews within the American Academy of Pediatrics' Guideline as a whole (n = 27), a mean of 47.8% of AMSTAR items were appropriately addressed, and a mean of 61% of PRISMA were appropriately reported. The means for items adhered to in the systematic reviews cited by Key Action Statements (n = 6) were 44.6% for AMSTAR and 67% for PRISMA. The means for items adhered to in the systematic reviews cited by consensus opinion (n = 10) were 41.6% for AMSTAR and 54% for PRISMA. Overall, the AMSTAR and PRISMA scores were highly correlated (r = 0.77). CONCLUSION: This study further substantiates the call for more quality evidence-based research in pediatric hypertension. The overall methodological and reporting quality of the systematic reviews were lacking in the American Academy of Pediatrics Guideline. Assessment of risk of bias across studies, identification of an accessible protocol, full disclosure of the role of funding entities, funding of included studies, and a complete PICOS statement were areas of greatest concern. These deficiencies should be addressed in future research in pediatric hypertension.

UR - http://www.scopus.com/inward/record.url?scp=85060924324&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000001870

DO - 10.1097/HJH.0000000000001870

M3 - Article

C2 - 30045363

AN - SCOPUS:85060924324

VL - 37

SP - 488

EP - 495

JO - Journal of hypertension

JF - Journal of hypertension

SN - 1473-5598

IS - 3

ER -